Figure 2From: Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug MonitoringIndividual Case Safety Reports (ICSR) suspecting anti-malarials submitted to UMC from 1968 to 2008.Back to article page